| molecular function |
|---|
| | GO:0005524 | | ATP binding | | Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| | GO:0005178 | | integrin binding | | Interacting selectively and non-covalently with an integrin. |
| | GO:0016301 | | kinase activity | | Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule. |
| | GO:0004715 | | non-membrane spanning protein tyrosine kinase activity | | Catalysis of the reaction: ATP + protein L-tyrosine = ADP + protein L-tyrosine phosphate by a non-membrane spanning protein. |
| | GO:0000166 | | nucleotide binding | | Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose. |
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0004672 | | protein kinase activity | | Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP. |
| | GO:0019901 | | protein kinase binding | | Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate. |
| | GO:0004674 | | protein serine/threonine kinase activity | | Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate. |
| | GO:0004713 | | protein tyrosine kinase activity | | Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate. |
| | GO:0004716 | | signal transducer, downstream of receptor, with protein tyrosine kinase activity | | Conveys a signal from an upstream receptor or intracellular signal transducer by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate. |
| | GO:0016740 | | transferase activity | | Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2. |
| biological process |
|---|
| | GO:0050853 | | B cell receptor signaling pathway | | A series of molecular signals initiated by the cross-linking of an antigen receptor on a B cell. |
| | GO:0038095 | | Fc-epsilon receptor signaling pathway | | A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region. |
| | GO:0038096 | | Fc-gamma receptor signaling pathway involved in phagocytosis | | An Fc-gamma receptor signaling pathway that contributes to the endocytic engulfment of external particulate material by phagocytes. |
| | GO:0007257 | | activation of JUN kinase activity | | The initiation of the activity of the inactive enzyme JUN kinase (JNK). |
| | GO:0000187 | | activation of MAPK activity | | The initiation of the activity of the inactive enzyme MAP kinase (MAPK). |
| | GO:0002250 | | adaptive immune response | | An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory). |
| | GO:0001525 | | angiogenesis | | Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels. |
| | GO:0009887 | | animal organ morphogenesis | | Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions. |
| | GO:0043366 | | beta selection | | The process in which successful recombination of a T cell receptor beta chain into a translatable protein coding sequence leads to rescue from apoptosis and subsequent proliferation of an immature T cell. |
| | GO:0048514 | | blood vessel morphogenesis | | The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood. |
| | GO:0008283 | | cell proliferation | | The multiplication or reproduction of cells, resulting in the expansion of a cell population. |
| | GO:0007166 | | cell surface receptor signaling pathway | | A series of molecular signals initiated by activation of a receptor on the surface of a cell. The pathway begins with binding of an extracellular ligand to a cell surface receptor, or for receptors that signal in the absence of a ligand, by ligand-withdrawal or the activity of a constitutively active receptor. The pathway ends with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0071404 | | cellular response to low-density lipoprotein particle stimulus | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a low-density lipoprotein particle stimulus. |
| | GO:0071226 | | cellular response to molecule of fungal origin | | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of fungal origin such as chito-octamer oligosaccharide. |
| | GO:0042742 | | defense response to bacterium | | Reactions triggered in response to the presence of a bacterium that act to protect the cell or organism. |
| | GO:0007167 | | enzyme linked receptor protein signaling pathway | | Any series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell, where the receptor possesses catalytic activity or is closely associated with an enzyme such as a protein kinase, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0002376 | | immune system process | | Any process involved in the development or functioning of the immune system, an organismal system for calibrated responses to potential internal or invasive threats. |
| | GO:0006954 | | inflammatory response | | The immediate defensive reaction (by vertebrate tissue) to infection or injury caused by chemical or physical agents. The process is characterized by local vasodilation, extravasation of plasma into intercellular spaces and accumulation of white blood cells and macrophages. |
| | GO:0045087 | | innate immune response | | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| | GO:0007229 | | integrin-mediated signaling pathway | | A series of molecular signals initiated by the binding of extracellular ligand to an integrin on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0035556 | | intracellular signal transduction | | The process in which a signal is passed on to downstream components within the cell, which become activated themselves to further propagate the signal and finally trigger a change in the function or state of the cell. |
| | GO:0002366 | | leukocyte activation involved in immune response | | A change in morphology and behavior of a leukocyte resulting from exposure to a specific antigen, mitogen, cytokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| | GO:0007159 | | leukocyte cell-cell adhesion | | The attachment of a leukocyte to another cell via adhesion molecules. |
| | GO:0019370 | | leukotriene biosynthetic process | | The chemical reactions and pathways resulting in the formation of leukotriene, a pharmacologically active substance derived from a polyunsaturated fatty acid, such as arachidonic acid. |
| | GO:0001945 | | lymph vessel development | | The process whose specific outcome is the progression of a lymph vessel over time, from its formation to the mature structure. |
| | GO:0002281 | | macrophage activation involved in immune response | | A change in morphology and behavior of a macrophage resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| | GO:0002283 | | neutrophil activation involved in immune response | | The change in morphology and behavior of a neutrophil resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor, leading to the initiation or perpetuation of an immune response. |
| | GO:0030593 | | neutrophil chemotaxis | | The directed movement of a neutrophil cell, the most numerous polymorphonuclear leukocyte found in the blood, in response to an external stimulus, usually an infection or wounding. |
| | GO:0018105 | | peptidyl-serine phosphorylation | | The phosphorylation of peptidyl-serine to form peptidyl-O-phospho-L-serine. |
| | GO:0038083 | | peptidyl-tyrosine autophosphorylation | | The phosphorylation by a protein of one or more of its own tyrosine amino acid residues, or a tyrosine residue on an identical protein. |
| | GO:0018108 | | peptidyl-tyrosine phosphorylation | | The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine. |
| | GO:0016310 | | phosphorylation | | The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide. |
| | GO:0030168 | | platelet activation | | A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug. |
| | GO:0045579 | | positive regulation of B cell differentiation | | Any process that activates or increases the frequency, rate or extent of B cell differentiation. |
| | GO:0046638 | | positive regulation of alpha-beta T cell differentiation | | Any process that activates or increases the frequency, rate or extent of alpha-beta T cell differentiation. |
| | GO:0046641 | | positive regulation of alpha-beta T cell proliferation | | Any process that activates or increases the frequency, rate or extent of alpha-beta T cell proliferation. |
| | GO:0045780 | | positive regulation of bone resorption | | Any process that activates or increases the frequency, rate or extent of bone resorption. |
| | GO:0050850 | | positive regulation of calcium-mediated signaling | | Any process that activates or increases the frequency, rate or extent of calcium-mediated signaling. |
| | GO:0033630 | | positive regulation of cell adhesion mediated by integrin | | Any process that activates or increases the frequency, rate, or extent of cell adhesion mediated by integrin. |
| | GO:0050715 | | positive regulation of cytokine secretion | | Any process that activates or increases the frequency, rate or extent of the regulated release of cytokines from a cell. |
| | GO:0045588 | | positive regulation of gamma-delta T cell differentiation | | Any process that activates or increases the frequency, rate or extent of gamma-delta T cell differentiation. |
| | GO:0045425 | | positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of granulocyte macrophage colony-stimulating factor. |
| | GO:0045401 | | positive regulation of interleukin-3 biosynthetic process | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-3. |
| | GO:0043306 | | positive regulation of mast cell degranulation | | Any process that activates or increases the frequency, rate or extent of mast cell degranulation. |
| | GO:0050731 | | positive regulation of peptidyl-tyrosine phosphorylation | | Any process that activates or increases the frequency, rate or extent of the phosphorylation of peptidyl-tyrosine. |
| | GO:0002092 | | positive regulation of receptor internalization | | Any process that activates or increases the frequency, rate or extent of receptor internalization. |
| | GO:0032481 | | positive regulation of type I interferon production | | Any process that activates or increases the frequency, rate, or extent of type I interferon production. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families. |
| | GO:0046777 | | protein autophosphorylation | | The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation). |
| | GO:0006468 | | protein phosphorylation | | The process of introducing a phosphate group on to a protein. |
| | GO:0031623 | | receptor internalization | | A receptor-mediated endocytosis process that results in the movement of receptors from the plasma membrane to the inside of the cell. The process begins when cell surface receptors are monoubiquitinated following ligand-induced activation. Receptors are subsequently taken up into endocytic vesicles from where they are either targeted to the lysosome or vacuole for degradation or recycled back to the plasma membrane. |
| | GO:0070372 | | regulation of ERK1 and ERK2 cascade | | Any process that modulates the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade. |
| | GO:0090237 | | regulation of arachidonic acid secretion | | Any process that modulates the rate, frequency, or extent of arachidonic acid secretion, the controlled release of arachidonic acid from a cell or a tissue. |
| | GO:0043313 | | regulation of neutrophil degranulation | | Any process that modulates the frequency, rate, or extent of neutrophil degranulation. |
| | GO:0050764 | | regulation of phagocytosis | | Any process that modulates the frequency, rate or extent of phagocytosis, the process in which phagocytes engulf external particulate material. |
| | GO:0010543 | | regulation of platelet activation | | Any process that modulates the rate or frequency of platelet activation. Platelet activation is a series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. |
| | GO:0090330 | | regulation of platelet aggregation | | Any process that modulates the rate, frequency or extent of platelet aggregation. Platelet aggregation is the adhesion of one platelet to one or more other platelets via adhesion molecules. |
| | GO:0051090 | | regulation of sequence-specific DNA binding transcription factor activity | | Any process that modulates the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| | GO:0032928 | | regulation of superoxide anion generation | | Any process that modulates the frequency, rate or extent of enzymatic generation of superoxide by a cell. |
| | GO:0010803 | | regulation of tumor necrosis factor-mediated signaling pathway | | Any process that modulates the rate or extent of the tumor necrosis factor-mediated signaling pathway. The tumor necrosis factor-mediated signaling pathway is the series of molecular signals generated as a consequence of tumor necrosis factor binding to a cell surface receptor. |
| | GO:0001820 | | serotonin secretion | | The regulated release of serotonin by a cell. Serotonin (5-hydroxytryptamine, or 5-HT) is a monoamine synthesised in serotonergic neurons in the central nervous system, enterochromaffin cells in the gastrointestinal tract and some immune system cells. |
| | GO:0002554 | | serotonin secretion by platelet | | The regulated release of serotonin by a platelet or group of platelets. |
| | GO:0002223 | | stimulatory C-type lectin receptor signaling pathway | | Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation. |
| | GO:0042991 | | transcription factor import into nucleus | | The directed movement of a transcription factor from the cytoplasm to the nucleus. |
| | GO:0007169 | | transmembrane receptor protein tyrosine kinase signaling pathway | | A series of molecular signals initiated by the binding of an extracellular ligand to a receptor on the surface of the target cell where the receptor possesses tyrosine kinase activity, and ending with regulation of a downstream cellular process, e.g. transcription. |
| | GO:0016032 | | viral process | | A multi-organism process in which a virus is a participant. The other participant is the host. Includes infection of a host cell, replication of the viral genome, and assembly of progeny virus particles. In some cases the viral genetic material may integrate into the host genome and only subsequently, under particular circumstances, 'complete' its life cycle. |
| cellular component |
|---|
| | GO:0019815 | | B cell receptor complex | | An immunoglobulin complex that is present in the plasma membrane of B cells and that in its canonical form is composed of two identical immunoglobulin heavy chains and two identical immunoglobulin light chains and a signaling subunit, a heterodimer of the Ig-alpha and Ig-beta proteins. |
| | GO:0042101 | | T cell receptor complex | | A protein complex that contains a disulfide-linked heterodimer of T cell receptor (TCR) chains, which are members of the immunoglobulin superfamily, and mediates antigen recognition, ultimately resulting in T cell activation. The TCR heterodimer is associated with the CD3 complex, which consists of the nonpolymorphic polypeptides gamma, delta, epsilon, zeta, and, in some cases, eta (an RNA splice variant of zeta) or Fc epsilon chains. |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0032009 | | early phagosome | | A membrane-bounded intracellular vesicle as initially formed upon the ingestion of particulate material by phagocytosis. |
| | GO:0031234 | | extrinsic component of cytoplasmic side of plasma membrane | | The component of a plasma membrane consisting of gene products and protein complexes that are loosely bound to its cytoplasmic surface, but not integrated into the hydrophobic region. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0005634 | | nucleus | | A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent. |
| | GO:0005886 | | plasma membrane | | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| | GO:0043234 | | protein complex | | A stable macromolecular complex composed (only) of two or more polypeptide subunits along with any covalently attached molecules (such as lipid anchors or oligosaccharide) or non-protein prosthetic groups (such as nucleotides or metal ions). Prosthetic group in this context refers to a tightly bound cofactor. The component polypeptide subunits may be identical. |
Description
